IGFBP5 and type 2 diabetes mellitus: Substantial reductions in mRNA expression levels were detected for LEP, CCL-5, ICAM-1, and IGFBP5, and an increase in IRS-2 in differentiated Non-T2D IPFP-ASCs compared to Non-T2D IPFP-ASCs (Figure 3B,D–G) was detected.